Orphan drugs treat rare diseases — life-threatening, seriously debilitating or serious chronic conditions that affect a small number of patients. On October 3, 2012, the Minister of Health announced that Health Canada is developing a modern framework for the designation, authorization and monitoring of orphan drugs in Canada. The announcement indicates that the proposed framework is in the final design stages and will soon be targeted for public consultation. The Government also launched Orphanet, an on-line resource for information regarding rare diseases.

News release.

Factsheet: An Orphan Drug Framework for Canada.

Factsheet: Orphanet-Canada.